PL192578A1 - Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow - Google Patents

Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow

Info

Publication number
PL192578A1
PL192578A1 PL19257876A PL19257876A PL192578A1 PL 192578 A1 PL192578 A1 PL 192578A1 PL 19257876 A PL19257876 A PL 19257876A PL 19257876 A PL19257876 A PL 19257876A PL 192578 A1 PL192578 A1 PL 192578A1
Authority
PL
Poland
Prior art keywords
arylacetamides
piperidinl
arylo
substituted
making new
Prior art date
Application number
PL19257876A
Other languages
English (en)
Polish (pl)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL192578A1 publication Critical patent/PL192578A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL19257876A 1975-09-23 1976-09-22 Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow PL192578A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
PL192578A1 true PL192578A1 (pl) 1979-02-26

Family

ID=27087421

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19257876A PL192578A1 (pl) 1975-09-23 1976-09-22 Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow
PL1976216213A PL117323B1 (en) 1975-09-23 1976-09-22 Process for preparing novel n-aryl-n-/4-piperidinyl/-arylacetamidesetoamidov

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1976216213A PL117323B1 (en) 1975-09-23 1976-09-22 Process for preparing novel n-aryl-n-/4-piperidinyl/-arylacetamidesetoamidov

Country Status (29)

Country Link
JP (1) JPS6016417B2 (enrdf_load_html_response)
AT (1) AT363935B (enrdf_load_html_response)
AU (1) AU510029B2 (enrdf_load_html_response)
BG (1) BG27543A3 (enrdf_load_html_response)
CA (1) CA1068271A (enrdf_load_html_response)
CH (1) CH628623A5 (enrdf_load_html_response)
CS (1) CS222663B2 (enrdf_load_html_response)
DE (1) DE2642856A1 (enrdf_load_html_response)
DK (1) DK150478C (enrdf_load_html_response)
ES (1) ES451768A1 (enrdf_load_html_response)
FI (1) FI61482C (enrdf_load_html_response)
FR (1) FR2325377A1 (enrdf_load_html_response)
GB (1) GB1539473A (enrdf_load_html_response)
GR (1) GR58469B (enrdf_load_html_response)
HU (1) HU172964B (enrdf_load_html_response)
IE (1) IE43802B1 (enrdf_load_html_response)
IL (1) IL50522A (enrdf_load_html_response)
IT (1) IT1073893B (enrdf_load_html_response)
LU (1) LU75837A1 (enrdf_load_html_response)
NL (1) NL187267C (enrdf_load_html_response)
NO (1) NO147672C (enrdf_load_html_response)
NZ (1) NZ181972A (enrdf_load_html_response)
PH (1) PH12497A (enrdf_load_html_response)
PL (2) PL192578A1 (enrdf_load_html_response)
PT (1) PT65631B (enrdf_load_html_response)
RO (1) RO70079A (enrdf_load_html_response)
SE (1) SE427839B (enrdf_load_html_response)
SU (1) SU747424A3 (enrdf_load_html_response)
YU (1) YU39973B (enrdf_load_html_response)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
KR101506156B1 (ko) 2007-04-23 2015-03-26 얀센 파마슈티카 엔.브이. 속해리성 도파민 2 수용체 길항제로서의 티아(디아)졸
HRP20120913T1 (hr) 2007-04-23 2012-12-31 Janssen Pharmaceutica N.V. Derivati 4-alkoksipiridazina kao brzo disocirajuä†i antagonisti dopamin 2 receptora
JP2010525013A (ja) * 2007-04-23 2010-07-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしてのピリジン誘導体
AU2009266001B2 (en) 2008-07-03 2014-03-27 Janssen Pharmaceutica Nv Substituted 6- (1-piperazinyl) -pyridazines as 5-HT6 receptor antagonists
CN102171189B (zh) 2008-07-31 2013-11-20 詹森药业有限公司 作为快速解离多巴胺2受体拮抗剂的哌嗪-1-基-三氟甲基取代的吡啶
CN118496638B (zh) * 2024-07-22 2024-11-22 海安浩驰科技有限公司 一种抗紫外车窗膜及其制备方法

Also Published As

Publication number Publication date
CS222663B2 (en) 1983-07-29
IL50522A0 (en) 1976-11-30
DE2642856C2 (enrdf_load_html_response) 1990-06-21
NO763054L (no) 1977-03-24
SE427839B (sv) 1983-05-09
GR58469B (en) 1977-10-14
SU747424A3 (ru) 1980-07-23
AU510029B2 (en) 1980-06-05
DK150478B (da) 1987-03-09
NO147672C (no) 1983-05-25
IL50522A (en) 1979-09-30
JPS5239683A (en) 1977-03-28
ES451768A1 (es) 1978-05-01
FI61482B (fi) 1982-04-30
SE7610501L (sv) 1977-03-24
YU39973B (en) 1985-06-30
FR2325377B1 (enrdf_load_html_response) 1980-04-18
FI762698A7 (enrdf_load_html_response) 1977-03-24
DK150478C (da) 1987-10-05
DE2642856A1 (de) 1977-03-24
IE43802B1 (en) 1981-06-03
JPS6016417B2 (ja) 1985-04-25
PL117323B1 (en) 1981-07-31
DK427876A (da) 1977-03-24
ATA702976A (de) 1981-02-15
CA1068271A (en) 1979-12-18
NL187267C (nl) 1991-08-01
PT65631A (en) 1976-10-01
LU75837A1 (enrdf_load_html_response) 1977-05-04
NO147672B (no) 1983-02-14
NZ181972A (en) 1978-07-28
NL187267B (nl) 1991-03-01
PT65631B (en) 1978-07-05
FI61482C (fi) 1982-08-10
PH12497A (en) 1979-04-05
GB1539473A (en) 1979-01-31
AU1787876A (en) 1978-03-23
AT363935B (de) 1981-09-10
CH628623A5 (en) 1982-03-15
RO70079A (ro) 1982-10-26
NL7610513A (nl) 1977-03-25
BG27543A3 (bg) 1979-11-12
YU233676A (en) 1983-01-21
IT1073893B (it) 1985-04-17
IE43802L (en) 1977-03-23
HU172964B (hu) 1979-01-28
FR2325377A1 (fr) 1977-04-22

Similar Documents

Publication Publication Date Title
PL211753A1 (pl) Sposob wytwarzania nowych 1,1-dwuoksydo-4-hydroksy-2h-1,2-benzotiazyno-3-karboksyamidow
PL192890A1 (pl) Sposob wytwarzania nowych 1-benzazoliloalkilo-4-podstawowych piperydyn
PL192578A1 (pl) Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow
PL193761A1 (pl) Sposob wytwarzania czteropierscieniowych chinonow
PL200251A1 (pl) Sposob wytwarzania nowych podstawionych 2-fenyloaminoimidazolin-/2/
PL193183A1 (pl) Sposob wytwarzania nowych pochodnych 11-dezoksy-16-arylo-omega-tetranorprostaglandyny
PL190247A1 (pl) Sposob wytwarzania nowych podstawionych heterocyklicznych n-alkanoloamin
PL192020A1 (pl) Sposob wytwarzania n-tetrahydrofurfurylo-noroksymorfonow
PL193861A1 (pl) Sposob wytwarzania alfa-aminoketonow
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL211919A1 (pl) Sposob wytwarzania nowych trans-4a-fenylo-2,3,4,4a,5,6,7,7a-oktahydro-1h-2-piryndyny
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL191156A1 (pl) Sposob wytwarzania nowych epoksyandrostanow
PL198731A1 (pl) Sposob wytwarzania nowych pochodnych 1-hydroksy-3-alkilodwubenzo/b,d/piranu
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu
PL201161A1 (pl) Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu
PL203486A1 (pl) Sposob wytwarzania nowych pochodnych 6,7-dwumetoksy-1,2,3,4-czterowodoro-1-izochinolino-acetamidu
PL100145B1 (pl) Sposob wytwarzania nowych zwiazkow dwuureidowych
PL203537A1 (pl) Sposob wytwarzania n,n-dwupodstawionych chlorowcoacyloamidow
PL196061A1 (pl) Sposob wytwarzania nowych pochodnych indolizyny
PL193604A1 (pl) Sposob wytwarzania nowych d-homosteroidow
PL201883A1 (pl) Sposob wytwarzania nowych pochodnych trans-5a-arylo-dziesieciowodorobenzazepiny
PL190303A1 (pl) Sposob wytwarzania nowych enamin
PL200287A1 (pl) Sposob wytwarzania 2,5-dwuhydroksybenzenosulfonianow

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20070106